These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

703 related items for PubMed ID: 18379559

  • 1. Upregulation of adipose 11-beta-hydroxysteroid dehydrogenase type 1 expression in ovariectomized rats is due to obesity rather than lack of estrogen.
    Paulsen SK, Nielsen MP, Richelsen B, Bruun JM, Flyvbjerg A, Pedersen SB.
    Obesity (Silver Spring); 2008 Apr; 16(4):731-5. PubMed ID: 18379559
    [Abstract] [Full Text] [Related]

  • 2. 11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization.
    Paulsen SK, Pedersen SB, Fisker S, Richelsen B.
    Obesity (Silver Spring); 2007 Aug; 15(8):1954-60. PubMed ID: 17712112
    [Abstract] [Full Text] [Related]

  • 3. Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss.
    Engeli S, Böhnke J, Feldpausch M, Gorzelniak K, Heintze U, Janke J, Luft FC, Sharma AM.
    Obes Res; 2004 Jan; 12(1):9-17. PubMed ID: 14742837
    [Abstract] [Full Text] [Related]

  • 4. Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome.
    Svendsen PF, Madsbad S, Nilas L, Paulsen SK, Pedersen SB.
    Int J Obes (Lond); 2009 Nov; 33(11):1249-56. PubMed ID: 19704410
    [Abstract] [Full Text] [Related]

  • 5. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects.
    Alberti L, Girola A, Gilardini L, Conti A, Cattaldo S, Micheletto G, Invitti C.
    Int J Obes (Lond); 2007 Dec; 31(12):1826-31. PubMed ID: 17593901
    [Abstract] [Full Text] [Related]

  • 6. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.
    Iwasaki Y, Takayasu S, Nishiyama M, Tsugita M, Taguchi T, Asai M, Yoshida M, Kambayashi M, Hashimoto K.
    Mol Cell Endocrinol; 2008 Mar 26; 285(1-2):10-8. PubMed ID: 18313835
    [Abstract] [Full Text] [Related]

  • 7. Depot-specific messenger RNA expression of 11 beta-hydroxysteroid dehydrogenase type 1 and leptin in adipose tissue of children and adults.
    Li X, Lindquist S, Chen R, Myrnäs T, Angsten G, Olsson T, Hernell O.
    Int J Obes (Lond); 2007 May 26; 31(5):820-8. PubMed ID: 17060929
    [Abstract] [Full Text] [Related]

  • 8. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
    Stimson RH, Walker BR.
    Minerva Endocrinol; 2007 Sep 26; 32(3):141-59. PubMed ID: 17912154
    [Abstract] [Full Text] [Related]

  • 9. Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats.
    Livingstone DE, Walker BR.
    J Pharmacol Exp Ther; 2003 Apr 26; 305(1):167-72. PubMed ID: 12649365
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients.
    Baudrand R, Domínguez JM, Carvajal CA, Riquelme A, Campino C, Macchiavello S, Bozinovic M, Morales M, Pizarro M, Solis N, Escalona A, Boza C, Arrese M, Fardella CE.
    Metabolism; 2011 Dec 26; 60(12):1775-80. PubMed ID: 21704348
    [Abstract] [Full Text] [Related]

  • 11. 17Beta-estradiol inhibits 11beta-hydroxysteroid dehydrogenase type 1 activity in rodent adipocytes.
    Tagawa N, Yuda R, Kubota S, Wakabayashi M, Yamaguchi Y, Kiyonaga D, Mori N, Minamitani E, Masuzaki H, Kobayashi Y.
    J Endocrinol; 2009 Jul 26; 202(1):131-9. PubMed ID: 19380458
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target.
    Wamil M, Seckl JR.
    Drug Discov Today; 2007 Jul 26; 12(13-14):504-20. PubMed ID: 17631244
    [Abstract] [Full Text] [Related]

  • 13. Expression and activity of 11beta-hydroxysteroid dehydrogenase type 1 enzyme in subcutaneous and visceral adipose tissue of prepubertal children.
    Mericq V, Medina P, Bouwman C, Johnson MC, Godoy J, López T, Iñiguez G.
    Horm Res; 2009 Jul 26; 71(2):89-93. PubMed ID: 19129713
    [Abstract] [Full Text] [Related]

  • 14. Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells.
    Ignatova ID, Kostadinova RM, Goldring CE, Nawrocki AR, Frey FJ, Frey BM.
    Am J Physiol Endocrinol Metab; 2009 Feb 26; 296(2):E367-77. PubMed ID: 19088256
    [Abstract] [Full Text] [Related]

  • 15. Estrogen reduces 11beta-hydroxysteroid dehydrogenase type 1 in liver and visceral, but not subcutaneous, adipose tissue in rats.
    Andersson T, Söderström I, Simonyté K, Olsson T.
    Obesity (Silver Spring); 2010 Mar 26; 18(3):470-5. PubMed ID: 19763091
    [Abstract] [Full Text] [Related]

  • 16. The expression of omental 11β-HSD1 is not increased in severely obese women with metabolic syndrome.
    Michalaki M, Kyriazopoulou V, Antonacopoulou A, Koika V, Nikolaou M, Tsoukas A, Kalfarentzos F, Vagenakis AG, Voukelatou G, Papavassiliou AG.
    Obes Facts; 2012 Mar 26; 5(1):104-11. PubMed ID: 22433622
    [Abstract] [Full Text] [Related]

  • 17. Antidiabetic effects of 11beta-HSD1 inhibition in a mouse model of combined diabetes, dyslipidaemia and atherosclerosis.
    Lloyd DJ, Helmering J, Cordover D, Bowsman M, Chen M, Hale C, Fordstrom P, Zhou M, Wang M, Kaufman SA, Véniant MM.
    Diabetes Obes Metab; 2009 Jul 26; 11(7):688-99. PubMed ID: 19527482
    [Abstract] [Full Text] [Related]

  • 18. Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice.
    Nuotio-Antar AM, Hachey DL, Hasty AH.
    Am J Physiol Endocrinol Metab; 2007 Dec 26; 293(6):E1517-28. PubMed ID: 17878220
    [Abstract] [Full Text] [Related]

  • 19. Role of 11-beta-hydroxysteroid dehydrogenase type 1 in differentiation of 3T3-L1 cells and in rats with diet-induced obesity.
    Liu Y, Sun WL, Sun Y, Hu G, Ding GX.
    Acta Pharmacol Sin; 2006 May 26; 27(5):588-96. PubMed ID: 16626514
    [Abstract] [Full Text] [Related]

  • 20. Expression profiles of human 11beta-hydroxysteroid dehydrogenases type 1 and type 2 in inflammatory bowel diseases.
    Stegk JP, Ebert B, Martin HJ, Maser E.
    Mol Cell Endocrinol; 2009 Mar 25; 301(1-2):104-8. PubMed ID: 19022342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.